Shedding light on shift work’s influence on cardiometabolic riskJanuary 16, 2018DiabetesLipid Disorders
CV outcomes better with SGLT2 inhibitor than DPP4 inhibitor in T2DM studyNovember 4, 2017DiabetesLipid Disorders
Weight recidivism after bariatric surgery: What constitutes failure?November 2, 2017ObesityLipid Disorders
Alirocumab’s ODYSSEY continues: Efficacy unaffected by insulin, beats fenofibrateSeptember 15, 2017DiabetesLipid Disorders
Most type 2 diabetes patients skipping metformin as first-line therapySeptember 13, 2017DiabetesLipid Disorders
Over 45% of American adults have type 2 diabetes mellitus or prediabetesJuly 20, 2017DiabetesLipid Disorders